Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria

20260 citationsJournal Articlegold Open Access

Authors

Giselle Mosnaim · Illinois Tool Works (United States)

Sarbjit S. Saini · Johns Hopkins University

Abstract

Despite limitations, our matching-adjusted indirect comparison analysis highlights that omalizumab is an effective treatment option for appropriate patients with chronic spontaneous urticaria.

Topics & Keywords

Urticaria and Related Conditions Dermatology and Skin Diseases Coagulation, Bradykinin, Polyphosphates, and Angioedema

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Journal of Allergy and Clinical Immunology Global

Volume 5, Issue 3, pp. 100668-100668

DOI: 10.1016/j.jacig.2026.100668

Field-Weighted Citation Impact: 0.00